Does TEDUGLUTIDE Cause Injection site mass? 72 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 72 reports of Injection site mass have been filed in association with TEDUGLUTIDE (Gattex). This represents 0.8% of all adverse event reports for TEDUGLUTIDE.
72
Reports of Injection site mass with TEDUGLUTIDE
0.8%
of all TEDUGLUTIDE reports
4
Deaths
50
Hospitalizations
How Dangerous Is Injection site mass From TEDUGLUTIDE?
Of the 72 reports, 4 (5.6%) resulted in death, 50 (69.4%) required hospitalization, and 2 (2.8%) were considered life-threatening.
Is Injection site mass Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TEDUGLUTIDE. However, 72 reports have been filed with the FAERS database.
What Other Side Effects Does TEDUGLUTIDE Cause?
Vascular device infection (1,009)
Weight decreased (991)
Product dose omission issue (937)
Diarrhoea (779)
Abdominal pain (714)
Nausea (682)
Weight increased (631)
Dehydration (615)
Vomiting (585)
Death (527)
What Other Drugs Cause Injection site mass?
EXENATIDE (3,506)
DUPILUMAB (2,243)
GLATIRAMER (2,172)
ETANERCEPT (2,101)
NALTREXONE (1,849)
TIRZEPATIDE (1,386)
LEUPROLIDE (1,359)
DULAGLUTIDE (1,319)
EVOLOCUMAB (1,254)
ADALIMUMAB (915)
Which TEDUGLUTIDE Alternatives Have Lower Injection site mass Risk?
TEDUGLUTIDE vs TEDUGLUTIDE\WATER
TEDUGLUTIDE vs TEGAFUR
TEDUGLUTIDE vs TEGAFUR\URACIL
TEDUGLUTIDE vs TEGASEROD
TEDUGLUTIDE vs TEGRETOL